BIIO (Bionovate Technologies) EBITDA Margin %: 0.00% (As of Sep. 2021)


What is Bionovate Technologies EBITDA Margin %?

Bionovate Technologies BIIO EBITDA Margin % is 0.00% as of Sep. 2021.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bionovate Technologies's EBITDA for the three months ended in Sep. 2021 was $-0.01 Mil. Bionovate Technologies's Revenue for the three months ended in Sep. 2021 was $0.00 Mil. Therefore, Bionovate Technologies's EBITDA margin for the quarter that ended in Sep. 2021 was 0.00%.

Bionovate Technologies  (OTCPK:BIIO) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Bionovate Technologies EBITDA Margin % Related Terms

Bionovate Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies EBITDA Margin % Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -5,600.00 0.00 0.00 0.00 0.00

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BIIO vs ABT, MDT, SYK: EBITDA Margin % Comparison

For the Medical Devices subindustry, Bionovate Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionovate Technologies EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionovate Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bionovate Technologies's EBITDA Margin % falls into.


Bionovate Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bionovate Technologies's EBITDA Margin % for the fiscal year that ended in Jun. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2021 )/Revenue (A: Jun. 2021 )
=-0.046/0
= %

Bionovate Technologies's EBITDA Margin % for the quarter that ended in Sep. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2021 )/Revenue (Q: Sep. 2021 )
=-0.006/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Bionovate Technologies (BIIO) has a EBITDA Margin % of 0.00% as of Sep. 2021. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' EBITDA Margin % too high?
Bionovate Technologies' current EBITDA Margin % is 0.00%.
How does Bionovate Technologies' EBITDA Margin % compare to ABT and MDT?
Bionovate Technologies' EBITDA Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bionovate Technologies and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionovate Technologies's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current EBITDA Margin % is 0.00% as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.